Page 154 - SAMRC Annual Report 2023-24
P. 154

A new request for applications for SIR grants      to date. The first cohort of 15 trainees commenced
            was issued in May 2023 with a closing date for     their training in February 2023 and the second
            submissions in June 2023. Proposals were invited   cohort of 11 started training in July 2023. Of these,
            in the following 12 research priority areas: HIV and   around 60% received placements for short-term
            TB; other infectious diseases including antimicrobial   industry internships. The SAMRC offered internships
            resistance;  maternal,  infant  and  child  health;  non-  to 4 students from cohort 1 who are now trainers
            communicable  diseases;  brain,  behaviour  and    of cohort 3 in 2024. As part of their training, the
            mental  health;  injury  and  interpersonal  violence;   interns were sent to Immunity Bio in Los Angeles
            occupational  and  environmental  health;  health   in November 2023 for advanced training. A third
            systems, health economics, Universal Health        cohort of 21 initiated their training in February 2024.
            Coverage  and  National  Health  Insurance;  African
            traditional  medicines;  vaccines,  diagnostics  and
            drug  discovery;  disease  prevention  and  health
            promotion;  and  One  Health.  Online  information
            sessions with prospective applicants were held
            prior to the submission date and this resulted in a
            significant  increase  in  the  number  of  applications
            received – 303 in 2023 versus 169 in 2022. The SAMRC
            also received fewer incomplete, ineligible and non-
            responsive  applications.  The  applications  have
            been peer-reviewed by  national  and international
            reviewers and approximately 40-50 awards will be
            made starting in the 2024/25 financial year.
            Other Initiatives


            Chan Soon-Shiong Family Foundation
            (CSSFF)-SAMRC Biomanufacturing
            Capacity Development Programme
            The SAMRC commenced a collaboration with the
            Chan  Soon-Shiong  Family  Foundation  (CSSFF)
            on a Biomanufacturing Capacity Development
            Programme during 2022/23. The collaboration is
            funded by a R100 million donation from the CSSFF
            and a R12 million contribution from the SAMRC. The
            programme  currently  has  4  components.  The  first
            involves providing technical training to graduates to
            equip them to work in a commercial biomanufacturing
            environment, including training in laboratory science,
            process engineering, quality assurance and scientific
            and research processes, such as experimental design
            and  scientific  writing.  The  training  is  delivered  by
            the SAMRC’s Biomedical Research and Innovation
            Platform (BRIP) and the Universities of Cape Town
            and  Stellenbosch.  Promising  candidates  who
            complete these studentships are offered industry     CSSFF SAMRC Interns and SAMRC
            internships or opportunities for postgraduate        Trainers Meeting Dr Patrick Soon-Shiong
            studies upon completion of their training. The first   at ImmunityBio in Los Angeles,
            call for studentships was launched in August 2022    November 2023.
            and 2 cohorts of students have completed training









            152         SAMRC  ANNUAL REPOR T 2023-24
   149   150   151   152   153   154   155   156   157   158   159